Steward Partners Investment Advisory, LLC Iovance Biotherapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 18,679 shares of IOVA stock, worth $99,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,679
Previous 10,197
83.18%
Holding current value
$99,372
Previous $95,000
45.26%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IOVA
# of Institutions
319Shares Held
244MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.5MShares$146 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$142 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$128 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$113 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$70.2 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $840M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...